Comment on “Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab”. // Annals of Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S1665268126000360?dgcid=rss_sd_all
Comment on “Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab”. Annals of Hepatology. https://www.sciencedirect.com/science/article/pii/S1665268126000360?dgcid=rss_sd_all
“Comment on “Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab”.” Annals of Hepatology.
@article{article88388,
title = {Comment on “Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab”},
journal = {Annals of Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S1665268126000360?dgcid=rss_sd_all}
}